Long-lasting complete remission in a patient with systemic metastases of recurrent breast cancer treated with cyclin-dependent kinases 4/6 inhibitors: a case report

BACKGROUND: The prognosis for recurrence cases of hormone receptor-positive HER2-negative breast cancer remains poor, and treatment strategies that emphasize quality of life have often been chosen, with few physicians aiming for a cure. Our objective is to assess the validity of such current treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoneto, Toshihiko, Hasumi, Kenichiro, Takahashi, Nobukazu, Seki, Nastuki, Takeda, Yasutaka, Yoshimoto, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169494/
https://www.ncbi.nlm.nih.gov/pubmed/37158934
http://dx.doi.org/10.1186/s13256-023-03902-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169494/
https://www.ncbi.nlm.nih.gov/pubmed/37158934
http://dx.doi.org/10.1186/s13256-023-03902-4

Ejemplares similares